Cases & Deals

Celgene invests in PTC Therapeutics

Clients Celgene Corporation

Jones Day advised Celgene Corporation in connection with its purchase of $20 million of Convertible Preferred Stock in a private placement by PTC Therapeutics, Inc., a biopharmaceutical company.